VEGF/mTOR combination for non-clear cell kidney cancer
The combination of vascular endothelial growth factor (VEGF)-directed and mammalian [...]
The combination of vascular endothelial growth factor (VEGF)-directed and mammalian [...]
Data presented at the American Society of Clinical Oncology (ASCO) [...]
Data presented at the American Society of Clinical Oncology (ASCO) annual [...]
Results from the phase III METEOR clinical trial, which compares [...]
The FDA has approved the combination of lenvatinib (Lenvima) and [...]
In a recent study published in the journal Lancet Oncology, [...]